Nature Webcast: Register Now!

Join us for a Nature Webcast on Wednesday, April 27th at 8am PST/ 11am EST! Dr. Shashi Murthy, professor at Northeastern University, will discuss releasable purification of monocytes for human dendritic cell generation.  Because dendritic cells (DCs) are present in very low concentrations (<1%) in blood, these cells must be generated from monocytes.  This presentation will discuss how MagCloudz can …

Overcoming the Roadblocks to Successful T-Cell Isolation

New Method for High-Efficiency Capture and Label-Free Release of High-Purity Target Cell Populations Cell-based therapeutics, such as CAR-T cancer therapies, are poised to transform 21st century medical care. These innovative medicines require highly specific isolation and purification of large numbers of viable, functional cells, a process that is often technically complex and cost-prohibitive. Consequently, demand is growing for novel approaches …

Novel Hydrogel-Based Approach for Cell Isolation, Purification and Release

The purification and enrichment of specific cell populations from complex starting samples is a critical component of multiple life science workflows. While the key objective of most protocols is to obtain a highly pure and viable population of cells for downstream applications and analysis, most do not meet this goal. Issues with conventional cell separation methods, such as traditional magnetic …

Quad Technologies Collaborates with University of Massachusetts Medical School to Highlight Benefits of Novel Cell Separation Solution

WOBURN, Mass.–(BUSINESS WIRE)–The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery. Quad Technologies (“Quad”), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with the University of Massachusetts Medical School to evaluate the …

Upcoming Event: Cell & Gene Therapy World Conference

Please join us at the Cell & Gene Therapy World Conference, January 25-27, 2016 in Washington, DC. Hear from more about MagCloudz from our CEO, Sean Kevlahan, during the “Technologies of Tomorrow” showcase theater on the exhibition hall floor. For more information, CLICK HERE.    

Nature OnDemand

Nature Webcast: Now Available On-Demand!

Blood Derived T-Cell Enrichment Using a Releasable Purification Technology Now available for on-demand viewing! Learn more about our innovative MagCloudz cell separation kit and hear from our collaborators at the University of Massachusetts whose research focuses on T-cell isolation for improved mouse models of human diseases. The live Q&A session was recorded and is available as part of the on-demand …

MagCloudz Streptavidin Cell Separation Kit

Quad Technologies Launches Fully Releasable Cell Separation Solution for Enhanced Cell Purity and Viability Following Successful Investment Round

WOBURN, Mass.–(BUSINESS WIRE)–The most promising areas of translational medical research, including CAR-T cancer therapies and stem cell-based regenerative medicine, require the isolation and purification of large numbers of viable, functional cells. There is growing demand from researchers and clinicians for technologies that provide high viability, enhanced efficiency and scalability to optimize conventional cell separation techniques. Read More…

Upcoming Event: American Society of Hematology Annual Meeting 2015

December 5-8, 2015 Orlando, FL   Come visit us at the 57th ASH Annual Meeting & Exposition, Booth #866! We look forward to meeting you and sharing about our new cell separation technology. More details about the meeting can be found by clicking the link below: More Info

Quad Team

Pioneering Separations Company Quad Technologies Set To Revolutionize Cell Isolation Following Successful Investment

February 17, 2015 Quad Technologies Inc (“Quad”), developer of a novel separation technology, has formally announced its entry into the cell separation market. Focused on overcoming barriers associated with conventional cell purification techniques, the company boasts remarkable scientific expertise, a wealth of business experience and comprehensive financial backing….Read More  

Sean Kevlahan Outer Space

Off to Outer Space!

November 13, 2013 “Hydrogels in space.” That was the cryptic text message Quad Technologies co-founder Brian Plouffe received from co-founder Sean Kevlahan at the end of last month. Plouffe, who was flying back from a conference in Orlando, knew exactly what it meant: The fledgling medical device company would get to fly an experiment involving its microbeads aboard the International …